Big pharma is looking... Here's an excerpt from
Post# of 72446
(Total Views: 318)
Posted On: 11/03/2017 10:50:43 AM
Big pharma is looking...
Here's an excerpt from SYN's CC yesterday...
Like I told you last quarter, we're talking to everybody Katherine at this point in time. I mean, there are discussions on for both drugs, from disparate companies. There's only a couple that are looking at both drugs together. The industry I think is beginning to look at licensing again. I think it's been pretty dry for the last two or three years from late stage Phase 2, Phase 3, the classic licensing deals. I think it's beginning to improve. Ken Frazier at Merck actually signaled that the other day that they were going to begin looking for things at Merck and I would guess that Pfizer said something similar as well in their earnings call. So I believe that the tide is going to turn for the big guys to start acquiring assets and filling their pipeline. So again, the only guidance I can give you is when we have a deal in hand and it becomes relevant, we'll announce it."
https://seekingalpha.com/article/4119328-synt...ipt?page=1
Of course I couldn't post this on the other board because it would get deleted. The money is out there.
Leo moving forward with FDA meetings to get the protocol aligned is the right way to go for both prurisol and brilacidin. Once that is set up, with input through the CDA's, then we'll see who our secrete admirers are.
IMO
Here's an excerpt from SYN's CC yesterday...
Like I told you last quarter, we're talking to everybody Katherine at this point in time. I mean, there are discussions on for both drugs, from disparate companies. There's only a couple that are looking at both drugs together. The industry I think is beginning to look at licensing again. I think it's been pretty dry for the last two or three years from late stage Phase 2, Phase 3, the classic licensing deals. I think it's beginning to improve. Ken Frazier at Merck actually signaled that the other day that they were going to begin looking for things at Merck and I would guess that Pfizer said something similar as well in their earnings call. So I believe that the tide is going to turn for the big guys to start acquiring assets and filling their pipeline. So again, the only guidance I can give you is when we have a deal in hand and it becomes relevant, we'll announce it."
https://seekingalpha.com/article/4119328-synt...ipt?page=1
Of course I couldn't post this on the other board because it would get deleted. The money is out there.
Leo moving forward with FDA meetings to get the protocol aligned is the right way to go for both prurisol and brilacidin. Once that is set up, with input through the CDA's, then we'll see who our secrete admirers are.
IMO
(4)
(0)